 Peter Luther |
Sard Verbinnen & Co. represents Montreal’s Atrium Innovations as the “science-based” natural supplements company agrees to be acquired by Nestle for $2.3B cash/debt.
Artrium markets products in more than 50 countries under brands such as Garden of Life, Douglas Laboratories, Genestra Brands and Pure Encapsulations.
CEO Peter Luther said Atrium shares Nestle Health Science group’s philosophy of “helping people lead healthier lives by providing good-for-you products that are made with the highest standards for quality and efficacy.”
Permira Funds, which has invested in more than 30 consumer companies such as Dr. Martens, Hugo Boss, John Masters Organics and Akindo Sushiro sushi restaurant company, controls Atrium.
SV&C’s Brooke Gordon, Devin Broda and Julie Rudnick handle the deal that is expected to close during the first-quarter of 2018.
Joele Frank handles Pine Gate Renewables as the Asheville, NC-based solar power development company declares Chapter 11 in the aftermath of Donald Trump’s cuts to wind & solar tax credits.
Stagwell CEO Mark Penn reports Q3 net revenues jumped 6 percent to $614.5M, a record performance for a non-political period. Operating income soared 45.7 percent to $60.9M.
Joele Frank works for Klöckner Pentaplast as the German maker of plastic films declares Chapter 11. A successful reorganization would slash its its corporate debt by $1.5B.
Teneo represents Metsera, the New York City biotech focused on weight-control products, which is subject to a bidding war between heavyweights Novo Nordisk and Pfizer.
Haggie Partners is working the $7B takeover of the specialty insurer Convex by Canada’s Onex private equity fund and American International Group.
